Parliamentary Report Rips India’s CDSCO on Drug Approvals, Colluding With Industry

As many as 33 new drugs approved for use in India between January 2008 and October 2010 — roughly one a month — never underwent clinical trials, according to a scathing parliamentary assessment of the Central Drugs Standard Control Organization (CDSCO) and its drug approval process.
International Pharmaceutical Regulatory Monitor